8 completed. 8 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Completed 8 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Cannabis: new trials by email Literature Review of Cannabis trials Research Report on Cannabis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Ingested Cannabidiol in Healthy Occasional Cannabis Users cannabis 0 mg, placebo, Cannabis 20 mg,, Cannabis 50 mg - Cannabis | Phase 1 / Phase 2 | Completed | Centre hospitalier de l'Université de Montréal (CHUM) | 70 | 2022-07-22 | 2024-04-22 |
| Repeated Cannabis Administration on Experimental Pain and Abuse Liability Active Cannabis, Placebo Cannabis - Cannabis, Pain | Phase 2 | Completed | New York State Psychiatric Institute | 10 | 2021-06-01 | 2025-08-08 |
| Efficacy of Inhaled Cannabis for Acute Migraine Treatment THC ~5%, CBD ~12%, THC ~5% and CBD ~12% - Migraine, Cannabis | Phase 2 | Completed | University of California, San Diego | 92 | 2020-11-20 | 2023-02-28 |
| Enhancing Medication-based Analgesia in Humans- STUDY 2 Within-subject test of blinded study medications - Pain, Cannabis | Phase 2 | Completed | Johns Hopkins University | 31 | 2020-02-01 | 2023-12-19 |
| Effect of Cannabis and Endocannabinoids on HIV Neuropathic Pain Cannabis - Cannabis, HIV Neuropathy | Phase 2 | Completed | University of California, San Diego | 5 | 2018-07-01 | 2024-06-18 |
| Myorelaxant Effect of Cannabis Cream Topical Skin Application in Patients With TMD Cannabis Cream, Placebo Cream - Temporomandibular Disorder, Myofascial Pain | Phase 2 / Phase 3 | Completed | Medical University of Silesia | 20 | 2018-01-01 | 2019-06-21 |
| Enhancing Medication-based Analgesia in Humans Within-subject test of blinded study medications - Pain, Cannabis | Phase 2 | Completed | Johns Hopkins University | 29 | 2016-12-01 | 2023-11-07 |
| Trial of Dronabinol and Vaporized Cannabis in Chronic Low Back Pain Placebos, dronabinol, Vaporized Cannabis 3.7% THC/5.6% CBD - Cannabis, Low Back Pain | Phase 2 | Completed | University of California, San Diego | 131 | 2016-12-01 | 2023-09-28 |
Marijuana Abuse (8) · Pain (3) · Agnosia (2) · Neuralgia (2) · Hyperalgesia (1) · Low Back Pain (1) · Migraine Disorders (1) · Somatoform Disorders (1) · Temporomandibular Joint Disorders (1)
Chemically-Induced Disorders (8) · Mental Disorders (8) · Substance-Related Disorders (8) · Nervous System Diseases (6) · Neurologic Manifestations (5) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (5) · Neurobehavioral Manifestations (2) · Neuromuscular Diseases (2) · Pain (2) · Perceptual Disorders (2) · Peripheral Nervous System Diseases (2) · Back Pain (1) · Brain Diseases (1) · Central Nervous System Diseases (1)
nabiximols (4) · Dronabinol (2) · Cannabidiol (1) · Sugars (1) · THC 5 (1) · salicylhydroxamic acid (1)
University of California, San Diego (3) · Johns Hopkins University (2) · Centre hospitalier de l'Université de Montréal (CHUM) (1) · Medical University of Silesia (1) · New York State Psychiatric Institute (1)
United States (6) · Canada (1) · Poland (1)
Claudia Campbell, PhD (2) · Brook L Henry, PhD (1) · Didier Jutras-Aswad, MD,MS (1) · Kelly Dunn, PhD (1) · Kelly E Dunn, PhD (1) · Nathaniel M Schuster, MD (1) · Thomas D Marcotte, PhD (1)
PMID 40839659, PMID 41469488, PMID 41514385, PMID 42454450
R01DA038634 (1), R01DA040644 (1)